ASCO GU 2022 | PSMA PET scans for prostate cancer

Neil Fleshner, MD, MPH, Princess Margaret Cancer Centre, Toronto, Canada, talks on the prostate specific antigen (PSMA) PET scan in prostate cancer. Critical trials in prostate cancer were presented at the American Society of Clinical Oncology (ASCO) Genitourinary Cancers (GU) Symposium 2022 that may hold the potential to change the standard of care (SOC). This interview took place at the American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium 2022 in San Francisco, CA.